TY - JOUR
T1 - Heartbeat signature for predicting motor and non-motor involvement among nonparkinsonian LRRK2 G2019S mutation carriers
AU - Carricarte Naranjo, Claudia
AU - Marras, Connie
AU - Visanji, Naomi P.
AU - Cornforth, David J.
AU - Sanchez‑Rodriguez, Lazaro
AU - Schüle, Birgitt
AU - Goldman, Samuel M.
AU - Estévez, Mario
AU - Stein, Phyllis K.
AU - Jelinek, Herbert F.
AU - Lang, Anthony E.
AU - Machado, Andrés
N1 - Publisher Copyright:
© Springer-Verlag GmbH Germany 2025.
PY - 2025
Y1 - 2025
N2 - Purpose: Increased beat-to-beat heart rate variability (HRV) is a feature of patients with Parkinson’s disease (PD) who carry the G2019S mutation in the LRRK2 gene (LRRK2-PD). Since LRRK2 mutations have incomplete penetrance, HRV changes preceding PD conversion would likely be observed only in a subset of LRRK2 non-manifesting carriers (NMC). We aimed to assess HRV in a subgroup of NMC with distinctive characteristics of LRRK2-PD, identified through clustering analysis. Methods: HRV measures derived from 300 normal heartbeat intervals extracted from the electrocardiograms of 25 NMC, 32 related non-carriers (RNC), 27 unrelated healthy controls, and 14 patients with LRRK2-PD were analyzed. Clinical symptoms were evaluated using questionnaires and scales, and three NMC subgroups were identified using a k-means cluster analysis on the basis of the deceleration capacity of heart rate (DC) and Rényi entropy. Standard and advanced HRV measures were compared using multiple regression analysis, controlling for age, sex, and mean heart rate. Results: Beat-to-beat HRV markers were significantly increased in a subgroup of seven NMC (NMC2, 28%) compared with RNC and controls. Increased irregularity and DC were also verified in the NMC2 compared with controls, and were typical traits in both the NMC2 and RNC. Overall, the HRV profile of NMC2 was comparable to that of patients with LRRK2-PD. NMC2 further exhibited greater motor and non-motor traits than the other NMC, RNC, and controls. Conclusions: Our results confirmed that HRV characteristics of LRRK2-PD are also found in a subset of NMC displaying clinical traits of LRRK2-PD. Further research is needed to clarify whether higher HRV represents a LRRK2-PD prodromal manifestation.
AB - Purpose: Increased beat-to-beat heart rate variability (HRV) is a feature of patients with Parkinson’s disease (PD) who carry the G2019S mutation in the LRRK2 gene (LRRK2-PD). Since LRRK2 mutations have incomplete penetrance, HRV changes preceding PD conversion would likely be observed only in a subset of LRRK2 non-manifesting carriers (NMC). We aimed to assess HRV in a subgroup of NMC with distinctive characteristics of LRRK2-PD, identified through clustering analysis. Methods: HRV measures derived from 300 normal heartbeat intervals extracted from the electrocardiograms of 25 NMC, 32 related non-carriers (RNC), 27 unrelated healthy controls, and 14 patients with LRRK2-PD were analyzed. Clinical symptoms were evaluated using questionnaires and scales, and three NMC subgroups were identified using a k-means cluster analysis on the basis of the deceleration capacity of heart rate (DC) and Rényi entropy. Standard and advanced HRV measures were compared using multiple regression analysis, controlling for age, sex, and mean heart rate. Results: Beat-to-beat HRV markers were significantly increased in a subgroup of seven NMC (NMC2, 28%) compared with RNC and controls. Increased irregularity and DC were also verified in the NMC2 compared with controls, and were typical traits in both the NMC2 and RNC. Overall, the HRV profile of NMC2 was comparable to that of patients with LRRK2-PD. NMC2 further exhibited greater motor and non-motor traits than the other NMC, RNC, and controls. Conclusions: Our results confirmed that HRV characteristics of LRRK2-PD are also found in a subset of NMC displaying clinical traits of LRRK2-PD. Further research is needed to clarify whether higher HRV represents a LRRK2-PD prodromal manifestation.
KW - Cardiac autonomic modulation
KW - Deceleration capacity of heart rate
KW - Heart rate variability
KW - LRRK2 mutation
KW - Parkinson’s disease
KW - Rényi entropy
UR - https://www.scopus.com/pages/publications/85218087938
U2 - 10.1007/s10286-024-01104-6
DO - 10.1007/s10286-024-01104-6
M3 - Article
AN - SCOPUS:85218087938
SN - 0959-9851
JO - Clinical Autonomic Research
JF - Clinical Autonomic Research
M1 - 106182
ER -